EGRX vs. IXHL, TELO, LFCR, OGI, GTHX, RIGL, GALT, ATOS, SGMT, and RZLT
Should you be buying Eagle Pharmaceuticals stock or one of its competitors? The main competitors of Eagle Pharmaceuticals include Incannex Healthcare (IXHL), Telomir Pharmaceuticals (TELO), Lifecore Biomedical (LFCR), Organigram (OGI), G1 Therapeutics (GTHX), Rigel Pharmaceuticals (RIGL), Galectin Therapeutics (GALT), Atossa Therapeutics (ATOS), Sagimet Biosciences (SGMT), and Rezolute (RZLT). These companies are all part of the "pharmaceutical preparations" industry.
Eagle Pharmaceuticals (NASDAQ:EGRX) and Incannex Healthcare (NASDAQ:IXHL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.
Eagle Pharmaceuticals currently has a consensus target price of $17.00, indicating a potential upside of 355.76%. Given Eagle Pharmaceuticals' higher possible upside, analysts plainly believe Eagle Pharmaceuticals is more favorable than Incannex Healthcare.
Eagle Pharmaceuticals has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, Incannex Healthcare has a beta of 8.36, indicating that its share price is 736% more volatile than the S&P 500.
Eagle Pharmaceuticals has higher revenue and earnings than Incannex Healthcare.
85.4% of Eagle Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.4% of Incannex Healthcare shares are owned by institutional investors. 28.9% of Eagle Pharmaceuticals shares are owned by company insiders. Comparatively, 14.6% of Incannex Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Eagle Pharmaceuticals received 412 more outperform votes than Incannex Healthcare when rated by MarketBeat users.
In the previous week, Eagle Pharmaceuticals and Eagle Pharmaceuticals both had 1 articles in the media. Incannex Healthcare's average media sentiment score of 0.95 beat Eagle Pharmaceuticals' score of 0.30 indicating that Incannex Healthcare is being referred to more favorably in the news media.
Summary
Eagle Pharmaceuticals beats Incannex Healthcare on 6 of the 9 factors compared between the two stocks.
Get Eagle Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Eagle Pharmaceuticals Competitors List
Related Companies and Tools
